Cargando…
Novel positron emission tomography imaging targeting cell surface glycans for pancreatic cancer: (18)F‐labeled rBC2LCN lectin
Advancement in early detection modalities will greatly improve the overall prognoses of pancreatic ductal adenocarcinoma (PDAC). For this purpose, we report a novel class of tumor‐specific probes for positron emission tomography (PET) based on targeting cell surface glycans. The PDAC‐targeting abili...
Autores principales: | Kuroda, Yukihito, Oda, Tatsuya, Shimomura, Osamu, Louphrasitthiphol, Pakavarin, Mathis, Bryan J., Tateno, Hiroaki, Hatano, Kentaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394132/ https://www.ncbi.nlm.nih.gov/pubmed/37203465 http://dx.doi.org/10.1111/cas.15846 |
Ejemplares similares
-
Lectin‐based phototherapy targeting cell surface glycans for pancreatic cancer
por: Kuroda, Yukihito, et al.
Publicado: (2022) -
Carcinoembryonic antigen as a specific glycoprotein ligand of rBC2LCN lectin on pancreatic ductal adenocarcinoma cells
por: Furuta, Tomoaki, et al.
Publicado: (2021) -
A technique for removing tumourigenic pluripotent stem cells using rBC2LCN lectin
por: Haramoto, Yoshikazu, et al.
Publicado: (2020) -
rBC2LCN lectin as a potential probe of early‐stage HER2‐positive breast carcinoma
por: Mawaribuchi, Shuuji, et al.
Publicado: (2020) -
Lectin drug conjugate therapy for colorectal cancer
por: Kitaguchi, Daichi, et al.
Publicado: (2020)